Autism medical therapy: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
Ssharfaei (talk | contribs)
editnews, nocaptcha, Administrators, Widget editors
7,502 edits
Ssharfaei (talk | contribs)
editnews, nocaptcha, Administrators, Widget editors
7,502 edits
Line 70: Line 70:


===Diets===
===Diets===
Atypical eating behavior occurs in about three-quarters of children with ASD, to the extent that it was formerly a diagnostic indicator. Selectivity is the most common problem, although eating rituals and food refusal also occur;<ref name="Dominick">{{cite journal |journal= Res Dev Disabil |year=2007 |volume=28 |issue=2 |pages=145–62 |title= Atypical behaviors in children with autism and children with a history of language impairment |author= Dominick KC, Davis NO, Lainhart J, Tager-Flusberg H, Folstein S |doi=10.1016/j.ridd.2006.02.003 |pmid=16581226}}</ref> this does not appear to result in [[malnutrition]]. Although some children with autism also have [[gastrointestinal]] (GI) symptoms, there is a lack of published rigorous data to support the theory that autistic children have more or different GI symptoms than usual;<ref>{{cite journal |journal= J Autism Dev Disord |date=2005 |volume=35 |issue=6 |pages=713–27 |title= Gastrointestinal factors in autistic disorder: a critical review |author= Erickson CA, Stigler KA, Corkins MR, Posey DJ, Fitzgerald JF, McDougle CJ |doi=10.1007/s10803-005-0019-4 |pmid=16267642}}</ref> studies report conflicting results, and the relationship between GI problems and ASD is unclear.<ref name="CCD">{{cite journal |journal=Pediatrics |date=2007 |volume=120 |issue=5 |pages=1162–82 |title= Management of children with autism spectrum disorders |author= Myers SM, Johnson CP, Council on Children with Disabilities |doi=10.1542/peds.2007-2362 |pmid=17967921 |url=http://pediatrics.aappublications.org/cgi/content/full/120/5/1162 |laysummary=http://www.aap.org/advocacy/releases/oct07autism.htm |laysource=AAP |laydate=2007-10-29}}</ref>
* There is no scientific evidence indicating effectiveness of different diets in patients with ASD. However, many testimonials can be found describing benefits of such diets in autism-related symptoms, notably social engagement and verbal skills.<ref name="Dominick">{{cite journal |journal= Res Dev Disabil |year=2007 |volume=28 |issue=2 |pages=145–62 |title= Atypical behaviors in children with autism and children with a history of language impairment |author= Dominick KC, Davis NO, Lainhart J, Tager-Flusberg H, Folstein S |doi=10.1016/j.ridd.2006.02.003 |pmid=16581226}}</ref><ref>{{cite journal |journal= J Autism Dev Disord |date=2005 |volume=35 |issue=6 |pages=713–27 |title= Gastrointestinal factors in autistic disorder: a critical review |author= Erickson CA, Stigler KA, Corkins MR, Posey DJ, Fitzgerald JF, McDougle CJ |doi=10.1007/s10803-005-0019-4 |pmid=16267642}}</ref>
 
* Diet low in [[gluten]] and [[casein]] is promoted in children with ASD.<ref>{{cite journal |author= Reichelt KL, Knivsberg A-M, Lind G, Nødland M |title= Probable etiology and possible treatment of childhood autism |journal= Brain Dysfunct |year=1991 |volume=4 |pages=308–19}}</ref>
In the early 1990s it was hypothesized that autism can be caused or aggravated by [[opioid peptide]]s like [[casomorphine]] that are metabolic products of [[gluten]] and [[casein]].<ref>{{cite journal |author= Reichelt KL, Knivsberg A-M, Lind G, Nødland M |title= Probable etiology and possible treatment of childhood autism |journal= Brain Dysfunct |year=1991 |volume=4 |pages=308–19}}</ref> Based on this hypothesis, diets that eliminate foods containing either gluten or casein, or both, are widely promoted, and many testimonials can be found describing benefits in autism-related symptoms, notably social engagement and verbal skills.
* Elimination diets targeting [[salicylates]], [[food dye]]s, [[yeast]], and simple sugars might be helpful in patients with ASD.<ref name="Christison">{{cite journal |journal= J Dev Behav Pediatr |date=2006 |volume=27 |issue=2 Suppl 2| pages=S162–71 |title= Elimination diets in autism spectrum disorders: any wheat amidst the chaff? |author= Christison GW, Ivany K |pmid=16685183}}</ref>
Studies supporting these claims have had significant flaws, so the data are inadequate to guide treatment recommendations.<ref name="Christison">{{cite journal |journal= J Dev Behav Pediatr |date=2006 |volume=27 |issue=2 Suppl 2| pages=S162–71 |title= Elimination diets in autism spectrum disorders: any wheat amidst the chaff? |author= Christison GW, Ivany K |pmid=16685183}}</ref>
 
Other elimination diets have also been proposed, targeting [[salicylates]], [[food dye]]s, [[yeast]], and simple sugars. No scientific evidence has established the efficacy of such diets in treating autism in children. An elimination diet may create nutritional deficiencies that harm overall health unless care is taken to assure proper nutrition.<ref name="Angley2" />
 
===Chelation Therapy===
Based on the speculation that [[heavy metals|heavy metal poisoning]] may trigger the symptoms of autism, particularly in small subsets of individuals who cannot excrete toxins effectively, some parents have turned to [[alternative medicine]] practitioners who provide detoxification treatments via [[chelation therapy]]. However, evidence to support this practice has been [[anecdote|anecdotal]] and not rigorous. There is strong [[epidemiology|epidemiological]] evidence that refutes links between environmental triggers, in particular [[thimerosal]] containing [[vaccine]]s, and the onset of autistic symptoms. No scientific data supports the claim that the mercury in the vaccine preservative [[thiomersal]] causes autism<ref>{{cite journal |journal= Can J Neurol Sci |date=2006 |volume=33 |issue=4 |pages=341–6 |title= Immunizations and autism: a review of the literature |author= Doja A, Roberts W |pmid=17168158}}</ref> or its symptoms,<ref>{{cite journal |journal= N Engl J Med |volume=357 |issue=13 |pages=1281–92 |year=2007 |title= Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years |author= Thompson WW, Price C, Goodson B ''et al.'' |pmid=17898097 |url=http://content.nejm.org/cgi/content/full/357/13/1281}}</ref> and there is no scientific support for chelation therapy as a treatment for autism.<ref name="Weber">{{cite journal |journal= Pediatr Clin North Am |date=2007 |volume=54 |issue=6 |pages=983–1006 |title= Complementary and alternative medical therapies for attention-deficit/hyperactivity disorder and autism |author= Weber W, Newmark S |doi=10.1016/j.pcl.2007.09.006 |pmid=18061787}}</ref>
 
Chelation therapy can be hazardous. In August 2005, botched chelation therapy killed a 5-year-old autistic boy, a nonautistic child died in February 2005 and an nonautistic adult died in August 2003. These deaths were due to [[cardiac arrest]] caused by [[hypocalcemia]] during chelation therapy.<ref name="hypocalcemia">{{cite journal |journal=Pediatrics |date=2006 |volume=118 |issue=2 |pages=e534-6 |title= Deaths resulting from hypocalcemia after administration of edetate disodium: 2003–2005 |author= Brown MJ, Willis T, Omalu B, Leiker R |doi=10.1542/peds.2006-0858 |pmid=16882789 |url=http://pediatrics.aappublications.org/cgi/content/full/118/2/e534}}</ref>
 
[[Thiamine]] tetrahydrofurfuryl disulfide (TTFD) is hypothesized to act as a chelating agent in children with autism. A 2002 pilot study administered TTFD rectally to ten [[autism spectrum]] children, and found beneficial clinical effect.<ref>{{cite journal |author=Lonsdale D, Shamberger RJ, Audhya T |title=Treatment of autism spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study |journal=Neuro Endocrinol. Lett |volume=23 |issue=4 |pages=303–8 |year=2002 |pmid=12195231 |url=http://www.nel.edu/pdf_w/23_4/NEL230402A02_Lonsdale_rw.pdf |format=PDF |accessdate=2007-08-10}}</ref> This study has not been replicated and a 2006 review of thiamine by the same author did not mention thiamine's possible effect on [[autism]].<ref>{{cite journal |journal= Evid Based Complement Alternat Med |date= 2006 |volume= 3 |issue= 1 |pages= 49–59 |title= A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives |author= Lonsdale D |10.1093/ecam/nek009 |pmid= 16550223 |url=http://ecam.oxfordjournals.org/cgi/content/full/3/1/49}}</ref> There is not sufficient evidence to support the use of thiamine (vitamin B1) to treat autism.<ref name="Angley2" />
 
===Craniosacral Therapy===
[[Craniosacral therapy]] is based on the theory that restrictions at [[cranial sutures]] of the skull affect rhythmic impulses conveyed via [[cerebrospinal fluid]]. Practitioners, who include physical therapists, chiropractors, dentists, osteopaths, medical, and naturopathic physicians, hypothesize that gentle pressure on external areas can improve the flow and balance of the supply of this fluid to the brain, relieving symptoms of many conditions.<ref name="Green" /> There is no scientific support for major elements of the underlying model, there is little scientific evidence to support the therapy, and research methods that could conclusively evaluate the therapy's effectiveness have not been applied.<ref name="Green">{{cite journal |journal=Complement Ther Med |year=1999 |volume=7 |issue=4 |pages=201–7 |title= A systematic review of craniosacral therapy: biological plausibility, assessment reliability and clinical effectiveness |author= Green C, Martin CW, Bassett K, Kazanjian A |doi=10.1016/S0965-2299(99)80002-8 |pmid=10709302}} An earlier version of the paper is available without a subscription: {{cite paper |title= A systematic review and critical appraisal of the scientific evidence on craniosacral therapy |author= Green C, Martin CW, Bassett K, Kazanjian A |url=http://www.chspr.ubc.ca/files/publications/1999/bco99-01J_cranio.pdf |format=PDF |date=1999 |accessdate=2007-10-08 |version= BCOHTA 99:1J |publisher= British Columbia Office of Health Technology Assessment}}</ref>


===Hyperbaric Oxygen Therapy===
===Hyperbaric Oxygen Therapy===
[[Hyperbaric oxygen therapy]] (HBOT) can compensate for decreased blood flow by increasing the oxygen content in the body. It has been postulated that HBOT might relieve some of the core symptoms of autism.<ref>{{cite journal |journal= Med Hypotheses |year=2007 |volume=68 |issue=6 |pages=1208–27 |title= Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism |author= Rossignol DA |doi=10.1016/j.mehy.2006.09.064 |pmid=17141962}}</ref> However, scientific evidence is lacking for the use of HBOT to treat autism.<ref name="Schechtman">{{cite journal |journal= Pediatr Ann |year=2007 |volume=36 |issue=8 |pages=497–8, 500–2, 504–5 |title= Scientifically unsupported therapies in the treatment of young children with autism spectrum disorders |author= Schechtman MA |pmid=17849608 |url=http://www.pediatricannalsonline.com/showPdf.asp?rID=23083 |format=PDF}}</ref>
* [[Hyperbaric oxygen therapy]] (HBOT)<ref>{{cite journal |journal= Med Hypotheses |year=2007 |volume=68 |issue=6 |pages=1208–27 |title= Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism |author= Rossignol DA |doi=10.1016/j.mehy.2006.09.064 |pmid=17141962}}</ref>
** It can increase the oxygen content of the body. HBOT might relieve some of the core symptoms of autism. However, scientific evidence is lacking for the use of HBOT to treat autism.<ref name="Schechtman">{{cite journal |journal= Pediatr Ann |year=2007 |volume=36 |issue=8 |pages=497–8, 500–2, 504–5 |title= Scientifically unsupported therapies in the treatment of young children with autism spectrum disorders |author= Schechtman MA |pmid=17849608 |url=http://www.pediatricannalsonline.com/showPdf.asp?rID=23083 |format=PDF}}</ref>


===Stem Cell Therapy===
===Stem Cell Therapy===
[[Mesenchymal stem cells]] and [[cord blood]] [[CD34]]+ cells have been proposed to treat autism, but this proposal has not been tested.<ref>{{cite journal |journal=J Transl Med |year=2007  |volume=5 |issue=30 |title= Stem cell therapy for autism |author= Ichim TE, Solano F, Glenn E ''et al.'' |doi=10.1186/1479-5876-5-30 |pmid=17597540 |url=http://www.translational-medicine.com/content/5/1/30}}</ref>
* [[Mesenchymal stem cells]] and [[cord blood]] [[CD34]]+ cells<ref>{{cite journal |journal=J Transl Med |year=2007  |volume=5 |issue=30 |title= Stem cell therapy for autism |author= Ichim TE, Solano F, Glenn E ''et al.'' |doi=10.1186/1479-5876-5-30 |pmid=17597540 |url=http://www.translational-medicine.com/content/5/1/30}}</ref>
** It have been proposed to treat autism.
 
==References==
==References==


Revision as of 03:27, 1 April 2018

Autism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Autism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Behavioral Therapy

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Autism medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Autism medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Autism medical therapy

CDC on Autism medical therapy

Autism medical therapy in the news

Blogs on Autism medical therapy

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Autism medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Many medications are used to treat problems associated with ASD.[1] More than half of U.S. children diagnosed with ASD are prescribed psychoactive drugs or anticonvulsants, with the most common drug classes being antidepressants, stimulants, and antipsychotics.[2] Aside from antipsychotics,[3] there is scant reliable research about the effectiveness or safety of drug treatments for adolescents and adults with ASD.[4] A person with ASD may respond atypically to medications, the medications can have adverse effects, and no known medication relieves autism's core symptoms of social and communication impairments.[5][6]

Medical Therapy

  • There is no pharmacologic medical therapy to completely cure autism spectrum disorder. However, pharmacologic medical therapy is recommended among patients with autism spectrum disorder to relieve common autistic symptoms such as seizures, sleep disturbances, irritability, and hyperactivity.[7][8]
  • Medical therapy must be accompanied by behavioral therapies to be more effective.
  • Risperidone is approved by FDA to control irritability for children between 5 years and 16 years of age.[9]
  • Other drugs might be used to improve symptoms of autism. However, drugs must be prescribed on a trial basis to check their efficacy and safety.

Autism

Adult

      • Preferred regimen (1): drug name 100 mg PO q12h for 10-21 days (Contraindications/specific instructions)
      • Preferred regimen (2): drug name 500 mg PO q8h for 14-21 days
      • Preferred regimen (3): drug name 500 mg q12h for 14-21 days
      • Alternative regimen (1): drug name 500 mg PO q6h for 7–10 days
      • Alternative regimen (2): drug name 500 mg PO q12h for 14–21 days
      • Alternative regimen (3): drug name 500 mg PO q6h for 14–21 days
    • 1.1.2 Pediatric
      • 1.1.2.1 (Specific population e.g. children 5-16 years of age)
        • Preferred regimen (1): risperidone

Note (1): Short term side effects are weight gain, drowsiness, and hyperglycemia.

        • Preferred regimen (2): drug name 30 mg/kg PO per day in 2 divided doses (maximum, 500 mg per dose)
        • Alternative regimen (1): drug name10 mg/kg PO q6h (maximum, 500 mg per day)
        • Alternative regimen (2): drug name 7.5 mg/kg PO q12h (maximum, 500 mg per dose)
        • Alternative regimen (3): drug name 12.5 mg/kg PO q6h (maximum, 500 mg per dose)
      • 1.1.2.2 (Specific population e.g. 'children < 8 years of age')
        • Preferred regimen (1): drug name 4 mg/kg/day PO q12h（maximum, 100 mg per dose）
        • Alternative regimen (1): drug name 10 mg/kg PO q6h (maximum, 500 mg per day)
        • Alternative regimen (2): drug name 7.5 mg/kg PO q12h (maximum, 500 mg per dose)
        • Alternative regimen (3): drug name 12.5 mg/kg PO q6h (maximum, 500 mg per dose)
  • selective serotonin reuptake inhibitors (SSRIs)[10]
  • fluvoxamine

Note: One of the most important side effects of SSRIs in children with ASD is suicidal impulses.

Supplements

  • Supplements might be used to alleviate the symptoms of autism.
  • High dose pyridoxine (vitamin B6) and magnesium (HPDM)
    • It is the most popular supplement that is used for autism. However, due to the limited data it is not scientifically proven to be more effective than placebo.[12][13][14]

Note: Side effect of high dose of pyridoxine is peripheral neuropathy in adults.

Note: Side effects of high doses of magnesium are bradycardia, weakened reflexes, and seizures.

  • Dimethylglycine (DMG)
    • It is used to improve speech and reduce autistic behaviors.
  • Vitamin C
    • In one study Vitamin C decreased stereotyped behavior.

Note: Side effects of high doses of vitamin C are kidney stones and diarrhea.

  • Probiotics
    • They are used to relieve some symptoms of autism by minimizing yeast overgrowth in the colon.[7]
  • Melatonin
    • It is used to manage sleep problems in developmental disorders.

Note: Side effects of melatonin are drowsiness, headache, dizziness, nausea, and an increase in seizure frequency among susceptible children.[12]

Diets

  • There is no scientific evidence indicating effectiveness of different diets in patients with ASD. However, many testimonials can be found describing benefits of such diets in autism-related symptoms, notably social engagement and verbal skills.[15][16]
  • Diet low in gluten and casein is promoted in children with ASD.[17]
  • Elimination diets targeting salicylates, food dyes, yeast, and simple sugars might be helpful in patients with ASD.[18]

Hyperbaric Oxygen Therapy

  • Hyperbaric oxygen therapy (HBOT)[19]
    • It can increase the oxygen content of the body. HBOT might relieve some of the core symptoms of autism. However, scientific evidence is lacking for the use of HBOT to treat autism.[20]

Stem Cell Therapy

References

  1. ↑ Leskovec TJ, Rowles BM, Findling RL (2008). "Pharmacological treatment options for autism spectrum disorders in children and adolescents". Harv Rev Psychiatry. 16 (2): 97–112. doi:10.1080/10673220802075852. PMID 18415882.
  2. ↑ Oswald DP, Sonenklar NA (2007). "Medication use among children with autism spectrum disorders". J Child Adolesc Psychopharmacol. 17 (3): 348–55. doi:10.1089/cap.2006.17303. PMID 17630868.
  3. ↑ Posey DJ, Stigler KA, Erickson CA, McDougle CJ (2008). "Antipsychotics in the treatment of autism". J Clin Invest. 118 (1): 6–14. doi:10.1172/JCI32483. PMID 18172517.
  4. ↑ Lack of research on drug treatments:
  5. ↑ Template:Cite paper
  6. ↑ Buitelaar JK (2003). "Why have drug treatments been so disappointing?". Novartis Found Symp. 251: 235–44, discussion 245–9, 281–97. doi:10.1002/0470869380.ch14. PMID 14521196.
  7. ↑ 7.0 7.1 7.2 Levy SE, Hyman SL (2005). "Novel treatments for autistic spectrum disorders". Ment Retard Dev Disabil Res Rev. 11 (2): 131–42. doi:10.1002/mrdd.20062. PMID 15977319.
  8. ↑ Schreibman L (2005). "Critical evaluation of issues in autism" (PDF). The Science and Fiction of Autism. Harvard University Press. ISBN 0674019318.
  9. ↑ Chavez B, Chavez-Brown M, Sopko MA Jr, Rey JA (2007). "Atypical antipsychotics in children with pervasive developmental disorders". Pediatr Drugs. 9 (4): 249–66. PMID 17705564.
  10. ↑ Myers SM (2007). "The status of pharmacotherapy for autism spectrum disorders". Expert Opin Pharmacother. 8 (11): 1579–603. doi:10.1517/14656566.8.11.1579. PMID 17685878.
  11. ↑ Posey DJ, Stigler KA, Erickson CA, McDougle CJ (2008). "Antipsychotics in the treatment of autism". J Clin Invest. 118 (1): 6–14. doi:10.1172/JCI32483. PMID 18172517.
  12. ↑ 12.0 12.1 12.2 Angley M, Semple S, Hewton C, Paterson F, McKinnon R (2007). "Children and autism—part 2—management with complementary medicines and dietary interventions" (PDF). Aust Fam Physician. 36 (10): 827–30. PMID 17925903.
  13. ↑ Francis K (2005). "Autism interventions: a critical update" (PDF). Dev Med Child Neurol. 47 (7): 493–9. PMID 15991872.
  14. ↑ Herbert JD, Sharp IR, Gaudiano BA (2002). "Separating fact from fiction in the etiology and treatment of autism: a scientific review of the evidence". S ci Rev Ment Health Pract. 1 (1): 23–43.
  15. ↑ Dominick KC, Davis NO, Lainhart J, Tager-Flusberg H, Folstein S (2007). "Atypical behaviors in children with autism and children with a history of language impairment". Res Dev Disabil. 28 (2): 145–62. doi:10.1016/j.ridd.2006.02.003. PMID 16581226.
  16. ↑ Erickson CA, Stigler KA, Corkins MR, Posey DJ, Fitzgerald JF, McDougle CJ (2005). "Gastrointestinal factors in autistic disorder: a critical review". J Autism Dev Disord. 35 (6): 713–27. doi:10.1007/s10803-005-0019-4. PMID 16267642.
  17. ↑ Reichelt KL, Knivsberg A-M, Lind G, Nødland M (1991). "Probable etiology and possible treatment of childhood autism". Brain Dysfunct. 4: 308–19.
  18. ↑ Christison GW, Ivany K (2006). "Elimination diets in autism spectrum disorders: any wheat amidst the chaff?". J Dev Behav Pediatr. 27 (2 Suppl 2): S162–71. PMID 16685183.
  19. ↑ Rossignol DA (2007). "Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism". Med Hypotheses. 68 (6): 1208–27. doi:10.1016/j.mehy.2006.09.064. PMID 17141962.
  20. ↑ Schechtman MA (2007). "Scientifically unsupported therapies in the treatment of young children with autism spectrum disorders" (PDF). Pediatr Ann. 36 (8): 497–8, 500–2, 504–5. PMID 17849608.
  21. ↑ Ichim TE, Solano F, Glenn E; et al. (2007). "Stem cell therapy for autism". J Transl Med. 5 (30). doi:10.1186/1479-5876-5-30. PMID 17597540.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Autism_medical_therapy&oldid=1458134"